67 related articles for article (PubMed ID: 7986335)
1. CD3- and CD28-activating pathways in HCV infection.
Corado JA; Toro FI; Baroja ML; Bianco NE; Machado IV
Viral Immunol; 1994; 7(1):37-40. PubMed ID: 7986335
[TBL] [Abstract][Full Text] [Related]
2. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
[TBL] [Abstract][Full Text] [Related]
4. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
6. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
Wu C; Warrier RR; Wang X; Presky DH; Gately MK
Eur J Immunol; 1997 Jan; 27(1):147-54. PubMed ID: 9022011
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic difference of T cells expanded with anti-CD3 monoclonal antibody in the presence and absence of anti-CD 28 monoclonal antibody.
Yamada-Ohnishi Y; Azuma H; Urushibara N; Yamaguchi M; Fujihara M; Kobata T; Ikeda H
Stem Cells Dev; 2004 Jun; 13(3):315-22. PubMed ID: 15186727
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
9. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood responses to specific antigens and CD28 in sarcoidosis.
Ahmadzai H; Cameron B; Chui JJ; Lloyd A; Wakefield D; Thomas PS
Respir Med; 2012 May; 106(5):701-9. PubMed ID: 22349068
[TBL] [Abstract][Full Text] [Related]
11. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.
Gruters RA; Terpstra FG; De Jong R; Van Noesel CJ; Van Lier RA; Miedema F
Eur J Immunol; 1990 May; 20(5):1039-44. PubMed ID: 2162775
[TBL] [Abstract][Full Text] [Related]
12. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
13. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
[TBL] [Abstract][Full Text] [Related]
15. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
[TBL] [Abstract][Full Text] [Related]
16. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
[TBL] [Abstract][Full Text] [Related]
18. Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients.
Nielsen SD; Afzelius P; Ersbøll AK; Nielsen JO; Hansen JE
Clin Exp Immunol; 1998 Oct; 114(1):66-72. PubMed ID: 9764605
[TBL] [Abstract][Full Text] [Related]
19. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
[TBL] [Abstract][Full Text] [Related]
20. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]